Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.86 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.86 |
| ▸ | DRD1 | P21728 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.52 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19214399 | 1.00 | ALDH1A1 (0.86) | ALDH1A1CYP2A6DRD1HDAC8HDAC6 | |
| SCHEMBL14667871 | 0.94 | ALDH1A1 (0.76) | ALDH1A1CYP2A6DRD1HDAC8HDAC6 | |
| Anisaldehyde SCHEMBL1100 | 0.93 | ALDH1A1 (1.00) | ALDH1A1CYP2A6ALDH1A3LMNATP53 | |
| Anisaldehyde SCHEMBL717471 | 0.93 | ALDH1A1 (1.00) | ALDH1A1CYP2A6ALDH1A3LMNATP53 | |
| Anisaldehyde SCHEMBL1477047 | 0.91 | ALDH1A1 (0.95) | ALDH1A1CYP2A6ALDH1A3LMNATP53 | |
| Anisaldehyde SCHEMBL28776745 | 0.91 | ALDH1A1 (0.95) | ALDH1A1CYP2A6ALDH1A3LMNATP53 | |
| Anisaldehyde SCHEMBL28557435 | 0.91 | ALDH1A1 (0.95) | ALDH1A1CYP2A6ALDH1A3LMNATP53 | |
| Anisaldehyde SCHEMBL11255570 | 0.91 | ALDH1A1 (0.95) | ALDH1A1CYP2A6ALDH1A3LMNATP53 | |
| Anisaldehyde SCHEMBL1475478 | 0.91 | ALDH1A1 (0.95) | ALDH1A1CYP2A6ALDH1A3LMNATP53 | |
| Anisaldehyde SCHEMBL31123393 | 0.91 | ALDH1A1 (0.95) | ALDH1A1CYP2A6ALDH1A3LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184587-A | Cyano-substituted benzimidazole luminescent compound and preparation method thereof | 中国科学院化学研究所 | 2024-06-14 | — | — | CN | claimed |
| CN-118006117-A | Long-life room-temperature phosphorescent nylon composite material and preparation method thereof | 中国科学院化学研究所 | 2024-05-10 | — | — | CN | claimed |
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | ORSOBIO INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20250391519-A1 | CHEMICAL SYNTHESIS PLATFORM | UNIV GLASGOW COURT (GB) | 2025-12-25 | — | — | US | disclosed |
| US-20250281515-A1 | CARBORANE COMPOUNDS, CARBORANE ANALOGS, AND METHODS OF USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2025-09-11 | — | — | US | disclosed |
| EP-4548355-A1 | CHEMICAL SYNTHESIS PLATFORM | The University Court Of The University Of Glasgow (GB) | 2025-05-07 | — | — | EP | disclosed |
| WO-2024226603-A1 | THERAPEUTIC COMPOUNDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2024-10-31 | — | — | WO | disclosed |
| CN-118184587-A | Cyano-substituted benzimidazole luminescent compound and preparation method thereof | 中国科学院化学研究所 | 2024-06-14 | — | — | CN | disclosed |
| CN-118006117-A | Long-life room-temperature phosphorescent nylon composite material and preparation method thereof | 中国科学院化学研究所 | 2024-05-10 | — | — | CN | disclosed |
| WO-2024003151-A1 | CHEMICAL SYNTHESIS PLATFORM | THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) | 2024-01-04 | — | — | WO | disclosed |
| US-11802106-B2 | Cathode buffer layer material and organic or organic/inorganic hybrid photoelectric device comprising same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-10-31 | — | — | US | disclosed |
| US-20030008768-A1 | Catalyst for aromatic C-O, C-N, and C-C bond formation | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-01-09 | — | — | US | disclosed |
| WO-2002096867-A2 | INHIBITORS OF PROTEIN KINASE FOR THE TREATMENT OF DISEASE | LG BIOMEDICAL INSTITUTE (US) | 2002-12-05 | — | — | WO | disclosed |
| WO-2002094767-A2 | TRISUBSTITUTED-N-[(1S)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENYL] BENZAMIDES WHICH INHIBIT P2X3 AND P2X2/3 CONTAINING RECEPTORS | ABBOTT LABORATORIES (US) | 2002-11-28 | — | — | WO | disclosed |
| US-20020173665-A1 | Trisubstituted-N-[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit P2X3 and P2X2/3 containing receptors | ABBOTT LABORATORIES | 2002-11-21 | — | — | US | disclosed |
| EP-1248109-A1 | Enantiomeric excess determination using a liquid crystal material | Rijksuniversiteit te Groningen (NL) | 2002-10-09 | — | — | EP | disclosed |
| WO-2002074752-A1 | METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | disclosed |
| WO-2002074750-A1 | METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | disclosed |
| WO-2002011883-A1 | CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION | YALE UNIVERSITY (US) | 2002-02-14 | — | — | WO | disclosed |
| US-3996210-A | OPTICAL BRIGHTENERS | SANDOZ LTD. (CH) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020173665-A1 | Trisubstituted-N-[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit P2X3 and P2X2/3 containing receptors | P2RX3, P2RX1, P2RX2 | ALDH1A1 404/4885CYP2A6 2291/4885DRD1 796/4885 |
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | CPT1B, CBR1, MUSK | ALDH1A1 290/4885CYP2A6 268/4885DRD1 1536/4885 |
| US-11802106-B2 | Cathode buffer layer material and organic or organic/inorganic hybrid photoelectric device comprising same | DCX, CDH1, CACNA2D3 | ALDH1A1 3065/4885CYP2A6 4656/4885DRD1 2219/4885 |
| US-20250391519-A1 | CHEMICAL SYNTHESIS PLATFORM | SET, CBS, COASY | ALDH1A1 2847/4885CYP2A6 440/4885DRD1 1416/4885 |
| US-20250281515-A1 | CARBORANE COMPOUNDS, CARBORANE ANALOGS, AND METHODS OF USE THEREOF | ESR2, ESRRB, ESRRA | ALDH1A1 1094/4885CYP2A6 761/4885DRD1 514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.